insights_auto
Why is QDEL down 2,07%?
Dive Deeperchevron_right
QDEL:NASDAQ
Quidelortho Corp
12,31 USD
arrow_downward
-2,07%(-0,26) 1D
12,51 USD
arrow_upward
+1,62% (+0,20)bedtimeAfter hours
Closed: 7-окт., 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for QDEL...
Open
12,34 USD
High
12,41 USD
Low
11,83 USD
Mkt. cap
844,16 млн
Avg. vol.
1,51 млн
Volume
0,00
52-wk high
35,58 USD
52-wk low
9,92 USD
EPS
-15,40 USD
Beta
0,79
Shares outstanding
68,58 млн
No. of employees
6 миң
Open
12,34 USD
High
12,41 USD
Low
11,83 USD
Mkt. cap
844,16 млн
Avg. vol.
1,51 млн
Volume
0,00
52-wk high
35,58 USD
52-wk low
9,92 USD
EPS
-15,40 USD
Beta
0,79
Shares outstanding
68,58 млн
No. of employees
6 миң
News stories
From web sources and news partners
Seeking Alpha
·
15 саат мурун
QuidelOrtho: Margins Recover, Cash Does Not (NASDAQ:QDEL)
Financial Times
·
20 саат мурун
QuidelOrtho Appoints Sanjeev Sharma as Vice President of Investor Relations – Company Announcement
GuruFocus
·
2 күн мурун
QuidelOrtho (QDEL) Shares Surge 12.7% on October 5, 2026, Amid E
Profile
QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide.
On May 8, 2020 the U.S. Food and Drug Administration issued to Quidel the first emergency use authorization for a COVID-19 rapid antigen test, a new category of tests for use in the ongoing pandemic. These diagnostic tests quickly detect fragments of proteins found on or within the virus by testing samples collected from the nasal cavity using swabs. Wikipedia
About Quidelortho Corp
CEODouglas C Bryant
Employees6,5 миң
Founded1979
HeadquartersСан Диего, Калифорния, Америка Кошмо Штаттары
SectorMedical device
Websitequidelortho.com